Description
Bayesian network meta-analysis ranking of AGA treatments by hair count change reveals the relative efficacy hierarchy among finasteride, minoxidil, PRP, LLLT, and combination therapies. Surface under the cumulative ranking curve (SUCRA) values are displayed.
FIGURE 2
Forest PlotSource Paper
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.Cite This Figure
 > Source: Peter R Feldman et al. "Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A syst." *Frontiers in medicine*, 2022. PMID: [36755885](https://pubmed.ncbi.nlm.nih.gov/36755885/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900126/bin/fmed-09-998623-g002.jpg" alt="Bayesian network meta-analysis ranking of AGA treatments by hair count change reveals the relative efficacy hierarchy among finasteride, minoxidil, PRP, LLLT, and combination therapies. Surface under the cumulative ranking curve (SUCRA) values are displayed." /> <figcaption>FIGURE 2. Bayesian network meta-analysis ranking of AGA treatments by hair count change reveals the relative efficacy hierarchy among finasteride, minoxidil, PRP, LLLT, and combination therapies. Surface under the cumulative ranking curve (SUCRA) values are displayed.<br> Source: Peter R Feldman et al. "Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A syst." <em>Frontiers in medicine</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36755885/">36755885</a></figcaption> </figure>
Related Evidence
A
Minoxidil for Androgenetic Alopecia
A
Grade A · 299 studies
Finasteride for Androgenetic Alopecia
A
Grade A · 206 studies
Nutrafol for Androgenetic Alopecia
A
Grade A · 3 studies
Low-Level Laser Therapy for Androgenetic Alopecia
A
Grade A · 60 studies
Viviscal for Telogen Effluvium
A
Grade A · 8 studies
Viviscal for Age-Related Hair Thinning
A
Grade A · 8 studies
Nutrafol for Female Pattern Hair Loss
A
Grade A · 8 studies
Nutrafol for Stress-Related Hair Loss
A
Grade A · 8 studies
Dutasteride for Androgenetic Alopecia
Grade A · 99 studies